Therefore, the binding of prorenin and PRR, blocked by PRO20, is expected to suppress the progression of renal fibrosis and abnormal renal function through inhibiting activation of the renin–angiotensin system to produce Ang II and prorenin/PRR-dependent intracellular signaling pathways. The gene discussed is REN; the disease is renal fibrosis.